alain hendlisz

Head of GI unit

Institut Jules Bordet

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Medical Imaging Medical Imaging professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Alain Hendlisz is the Head of the GI unit at Institut Jules Bordet in Belgium. His research primarily focuses on gastrointestinal oncology, particularly in the prognostic factors and treatment outcomes of pancreatic and colorectal cancers. Recent articles include studies on clinical radiomics, circulating cytokines, and the effectiveness of various chemotherapy regimens in advanced cancer settings.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Henry Woodruff

Assistant Professor

University of Maastricht

NETHERLANDS

View details

Paul Ross

King's College Hospital

UNITED KINGDOM

View details

Gabriel Liberale

Université libre de Bruxelles

BELGIUM

View details

Mehrdad Nikfarjam

Professor

University of Melbourne

AUSTRALIA

View details

Daniel Croagh

Lecturer

MONASH UNIVERSITY

AUSTRALIA

View details

Thomas Guiot

Université libre de Bruxelles

BELGIUM

View details

Eric Van Cutsem

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

alain hendlisz

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study

Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer

Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases

Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy

First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

JCOG0603: Are We Really Sure This Was a Negative Trial?

The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer

Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials

Buschke-löwenstein tumor in a human immunodeficiency virus-positive patient: A case report and short literature review

Collaborators (7)

Henry Woodruff

Paul Ross

Gabriel Liberale

Mehrdad Nikfarjam

Daniel Croagh

Thomas Guiot

Eric Van Cutsem

Make your next move.